Salmonid IPN: distinguish carriage from clinical disease

Start by separating infection from clinical disease

Infectious pancreatic necrosis, usually abbreviated to IPN, affects farmed salmonids. Its causative agent, IPNV, can persist in fish without an ongoing episode of clinical disease. A positive laboratory result and mortality attributed to IPN therefore answer different questions. Keeping those questions separate is useful when reviewing a hatchery incident or considering a movement between production units.

The Norwegian Veterinary Institute makes this distinction in its 2024 fish health report. Disease diagnosis combines histological lesions with immunolabelling of the virus in affected tissue. Cell culture and real-time RT-PCR can detect the agent, but detection alone does not establish that IPN caused the clinical problem. The reasoning is relevant internationally; Norwegian surveillance figures describe a particular national system and cannot be used as estimates for France or another country.

Before requesting testing, identify the decision that the result should support. Is the purpose to investigate a mortality event, document virus circulation or assess a proposed transfer? A request headed simply “test for IPN” can leave those objectives unresolved. A clear question helps the veterinarian and laboratory select an appropriate investigation and explain what its outcome can establish.

Reconstruct the event before collecting samples

For increased mortality, assemble a dated history of the group: source, life stage, stock numbers, tank changes, feeding, handling and daily losses. Add available water measurements with their units, sampling locations and times. A measurement made after an incident cannot necessarily reconstruct the conditions that preceded it, even when it appears reassuring.

Separate observations affecting the whole facility from those restricted to one tank. Are groups from the same source affected together? Did the change follow handling or a movement? These observations do not prove a cause. They help organise competing explanations and identify the fish and locations that may provide useful evidence.

An agent already known to occur on a site should not become the default explanation for every subsequent loss. More than one problem may be present, and an IPNV detection may be incidental to another condition. Retain clinical observations and negative findings so that an early positive result does not remove alternative explanations from the record.

Agree the investigation with the laboratory

Discuss fish selection, tissues, containers, storage and shipping before sampling begins. Material intended for histology and material intended for virological testing may require different preparation. Instructions agreed in advance are more useful than trying to recover the missing information once a parcel has already been dispatched.

Give each sample an identifier linked to its source group and tank. Record the reason for selecting that fish and any previous treatment. The aim is to connect molecular findings with lesions in the same animal where possible. When different fish provide the different samples, preserve that distinction rather than presenting the evidence as if it came from one individual.

A useful interpretation describes both agreement and gaps between findings. Detection of an agent, compatible lesions and a supported diagnosis should remain distinguishable outcomes. Where the evidence is insufficient, an additional sample or a focused period of observation may be the appropriate next step. An unresolved result does not automatically create an indication for treatment.

Genetic resistance does not replace the health record

Espinoza and colleagues’ 2026 molecular review describes IPNV as a double-stranded RNA virus and notes persistent infection in surviving fish. It also discusses genetically resistant stocks and variants associated with disease in resistant fish. Protection must consequently be interpreted in its biological context rather than treated as proof that infection is impossible.

For farm records, we suggest keeping three separate fields: genetic origin, health history and actual test findings. A source document or a commercial description does not replace observations made after arrival. Equally, a positive viral result cannot by itself establish that a stock has lost every benefit associated with its resistance background.

Decisions should reflect the group and receiving system, including exposed populations and realistic options for separation. Veterinary input can help relate the evidence to the intended movement. Neither the molecular review nor the national report supplies a universal molecular cut-off or mortality threshold for making that decision.

Map the contacts that matter

A practical biosecurity discussion can begin with a map of animal arrivals, water connections, shared equipment, staff movements and waste routes. Draw the actual operating arrangements rather than the intended ones. Tanks that appear far apart may remain connected by water or equipment; a boundary on a floor plan may disappear during routine work.

We recommend defining who can authorise fish movements while health status remains uncertain and what information that person must receive. Record events that change exposure after a test has been completed. An earlier health assessment retains its original date and scope; it should not silently become an assessment of the day on which fish are moved.

These are proposed management arrangements, not a treatment schedule or a statement of French law. Requirements for movements depend on species, territory and destination and must be checked in their own right. The legal position described in the Norwegian report should not be transferred to another jurisdiction.

Conclusion: connect evidence to a specific action

An IPN investigation is most useful when stock history, clinical observations, tissue findings and virology are considered together. The presence of IPNV and its contribution to a particular incident require separate interpretation. That distinction supports proportionate decisions and makes the uncertainty understandable to everyone responsible for neighbouring stocks.

Vetofish can help plan sampling and interpret the resulting case record through our diagnostic and analytical services. Our work with aquaculture operations connects those findings to the facility’s contact network, stock movements and next health management decision. A review can identify which information is already sufficient, which remains missing and how it could be collected without treating every positive result as an identical event.